MedTrace Logo

Immune Response to Varicella Vaccination in Children With Atopic Dermatitis

NCT00406081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2017-01-11

No results posted yet for this study

Summary

Atopic dermatitis (AD) causes people to be susceptible to skin infection and inflammations. The purpose of this study is to determine the immune response to chicken pox vaccine in children with or without AD who received the vaccine 2 to 16 weeks prior to the study visit.

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Lynda Schneider, MD · Boston Children's Hospital

  • Donald Y. Leung, MD, PhD · National Jewish Health

Eligibility

Min Age
12 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00406081 on ClinicalTrials.gov